Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about GILD
Recent news which mentions GILD
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Where Gilead Sciences Stands With Analysts
April 04, 2022
Tickers
GILD
Tags
BZI/AAR
Market News
GILD
From
Benzinga
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
April 04, 2022
Tickers
GILD
Tags
Benzinga
GILD
Earnings
From
Benzinga
10 Biggest Price Target Changes For Monday
April 04, 2022
Tickers
BAX
CALA
CARR
GILD
Tags
Penny Stocks
TRV
PZZA
From
Benzinga
Gilead's Yescarta Scores FDA Approval As First CAR T-Cell Therapy For Earlier Lymphoma
April 04, 2022
Tickers
GILD
Tags
Benzinga
General
Market News
From
Benzinga
2 Drugmakers Set for Explosive Revenue This Decade
April 03, 2022
Tickers
ABBV
AZN
BMY
GILD
Tags
OPHLY
Market News
BMY
From
Motley Fool
The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall
March 31, 2022
Tickers
ADMP
AFIB
AFMD
AMLX
Tags
AFIB
PDSB
INVO
From
Benzinga
5 Charts That Show Why Bristol-Myers Squibb Is a No-Brainer Buy
March 30, 2022
Tickers
ABBV
BMY
BNTX
GILD
Tags
Market News
LLY
OPHLY
From
Motley Fool
Investors Seek Second Act with Moderna Stock
March 29, 2022
Tickers
GILD
MRNA
Tags
Stocks to Buy
NASDAQ:MRNA,NASDAQ:GILD
MRNA
From
InvestorPlace
FDA Says Current Dose Of GSK-Vir's COVID-19 Therapy Unlikely To Work Against Omicron Subvariant
March 28, 2022
Tickers
GILD
GSK
LLY
MRK
Tags
PFE
MRK
Benzinga
From
Benzinga
2 High-Yielding Stocks Trading Near Multiyear Lows
March 23, 2022
Tickers
GILD
UL
Tags
UL
GILD
Market News
From
Motley Fool
10 Biggest Price Target Changes For Monday
March 22, 2022
Tickers
COIN
ETON
GILD
GRPH
Tags
Price Target Changes
PDD
GRPH
From
Benzinga
What Cramer Thinks About Hims & Hers Health, Gilead Sciences And More
March 21, 2022
Tickers
DKNG
EPD
GILD
HIMS
Tags
TWO
Short Sellers
Markets
From
Benzinga
Todos Medical Acquires Lucrative NLC Assets For Pennies On The Dollar
March 16, 2022
Tickers
GILD
MRK
PFE
TOM
Tags
GILD
TOM
Biotech
From
Benzinga
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
March 11, 2022
Tickers
GILD
Tags
Benzinga
GILD
Earnings
From
Benzinga
Gilead Sciences' Trodelvy Study In Breast Cancer Meets Primary Endpoint
March 07, 2022
Tickers
GILD
Tags
GILD
Phase 3 Trial
Briefs
From
Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
March 06, 2022
Tickers
ACHV
ACOR
AMPH
AMYT
Tags
General
Market News
RGLS
From
Benzinga
36 Stocks To Watch After Biden's First State of The Union Address
March 02, 2022
Tickers
ABBV
ABT
AMGN
AOUT
Tags
mental health
RGR
ABT
From
Benzinga
Gilead Hit By FDA Complete Response Letter For Lenacapavir In HIV Infection
March 01, 2022
Tickers
GILD
Tags
General
Benzinga
HIV treatment
From
Benzinga
Where Gilead Sciences Stands With Analysts
February 28, 2022
Tickers
GILD
Tags
Market News
Analyst Ratings
GILD
From
Benzinga
Stocks That Hit 52-Week Lows On Monday
February 28, 2022
Tickers
AAOI
ALPA
AMBC
AMYT
Tags
MNKD
Movers
TCX
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2022
February 28, 2022
Tickers
ABBV
AEP
AMAM
ATHM
Tags
BZI/Ratings
PCTY
Market News
From
Benzinga
A Peek Into The Markets: US Stock Futures Tumble Following New Sanctions Against Russia
February 28, 2022
Tickers
BRO
GILD
HPQ
IGT
Tags
WRB
XRAY
A Peek Into The Markets
From
Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
Tickers
ACAD
ACLX
AMRN
AMRS
Tags
ACAD
IPOs
EPZM
From
Benzinga
3 Pharma Stocks That Retired Investors Should Love
February 26, 2022
Tickers
ABBV
ABT
GILD
GSK
Tags
ABT
GSK
GILD
From
Motley Fool
3 Moonshot Stocks Insiders Are Buying. What Do They Know?
February 25, 2022
Tickers
CLOV
CRL
CSII
FFIE
Tags
Market Insight, Financial Articles
JOBY
CLOV
From
InvestorPlace
Is Moderna the Next Gilead or the Next Regeneron?
February 22, 2022
Tickers
GILD
MRK
MRNA
REGN
Tags
REGN
GILD
Hot Stocks
From
InvestorPlace
See Why Did FDA Update Merck's COVID-19 Pill Emergency Use Authorization
February 18, 2022
Tickers
GILD
MRK
Tags
FDA
Health Care
Biotech
From
Benzinga
Want To Collect $200 Every Month? Invest $49,334 in These 3 Stocks
February 18, 2022
Tickers
GILD
GSK
VZ
Tags
Recent Press Releases
VZ
GILD
From
Motley Fool
These 3 Stocks Just Declared Dividend Raises
February 18, 2022
Tickers
GILD
MMM
PEP
Tags
PEP
Recent Press Releases
MMM
From
Motley Fool
Gilead's Lenacapavir Shows Sustained Efficacy In Pretreated HIV Patients
February 17, 2022
Tickers
GILD
Tags
HIV treatment
Benzinga
General
From
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today